Authors
Latest:
United Urology Group and its affiliate practices and Prostate Centers USA® are collaborating to revolutionize men's health care with minimally invasive solutionsThe inclusion of PAE in the American Urological Association BPH Guidelines offers a non-surgical alternative that can provide long-term relief with minimal downtime and fewer complications, according to the United Urology Group.
Latest:
Triplet therapy including darolutamide should be standard of care in mCSPC, data indicateResults of the ARASENS trial (NCT02799602) demonstrated that darolutamide plus ADT and docetaxel prolonged overall survival regardless of disease volume or risk.
Latest:
Real-world data point to underutilization of germline, somatic testing in mCRPC"Certainly germline and somatic is recommended for all mCRPC patients to detect HR gene mutations, and consider options for PARP inhibitors,” says Neal Shore, MD, FACS.
Latest:
Chronic orchialgia: How to diagnose and treat the challenging conditionIn this interview, Parviz K. Kavoussi, MD, discusses his diagnostic work-up for patients who present with chronic testicular pain and describes conservative and surgical management approaches for the condition.
Latest:
Expert explains why automation is key to prior authorization reformAutomating prior authorization is an investment that every health care organization should consider. As the industry grapples with rapid regulatory shifts and acute staff shortages, a tailored automation strategy is key to enhancing patient care and improving operational efficiency.
Latest:
How data and technology facilitate health equity and boost the overall patient experience"Digital engagement technology, which can be seamlessly integrated into a health system or hospital's existing processes," writes Chelsea King Arthur.
Latest:
Enhancing Patient-Centric Management in OAB in 2024 and BeyondPanelists conclude their discussion by reflecting on key learnings and sharing advice for patient-centric management in overactive bladder (OAB) treatment, specifically focusing on effective communication and overlooked aspects of patient care. They offer guidance to other providers on enhancing patient experiences, particularly with procedures like Botox. The episode wraps up with each expert sharing their final thoughts and anticipations for advancements in OAB treatment in 2024, highlighting their commitment to addressing patient needs in this evolving field.
Latest:
Is a medical scribe right for your practice?“Regardless of the size of the practice, medical scribes are a valuable resource for health care providers, helping to streamline workflow and coordinate patient care,” writes Brian Hudson.
Latest:
Diagnostic stewardship for urinary tract infection: A snapshot of the expert guidanceUrinary tract infections (UTIs) are among the most common human infections. But the urine culture, the cornerstone for laboratory diagnosis of UTI, is imperfect.
Latest:
Combo of cabozantinib and pembrolizumab shows promise in frontline urothelial carcinomaResults from the phase 2 PemCab trial showed that the first-line combination elicited promising antitumor activity with tolerable toxicity in patients with advanced urothelial carcinoma, including those who were cisplatin ineligible.
Latest:
PARP inhibitors, imaging and diagnostic advances among recent prostate cancer highlights“The impact of precision medicine in prostate cancer has been significant over a relatively brief period,” says Leonard G. Gomella, MD, FACS.
Latest:
Clinical Insights on Evolving Treatment Landscape in Urothelial CarcinomaScott T. Tagawa, MD, MS, FACP, FASCO, offers a comprehensive look at the evolving treatment landscape, with a focus on practical considerations and ongoing research.
Latest:
Dr. Gupta highlights the latest developments in muscle-invasive bladder cancerShilpa Gupta, MD, shares her expert insight on the evolving treatment paradigm for patients with muscle-invasive bladder cancer, along with obstacles that must be overcome to further advance the field.
Latest:
How to assemble a Thompson Retractor for midline transabdominal retroperitoneal surgeryThe patient presented with a large right renal mass who elected for right radical nephrectomy with possible inferior vena cava.
Latest:
Clinical Insights on Optimal Perirectal SpacingIn the third article of this series, Amar U. Kishan, MD, provides clinical insights on the use of perirectal spacers for patients who receive hypofractionated radiation or SBRT.
Latest:
Tips for successfully mentoring other physiciansHere are some helpful hints for launching your physician mentor-mentee relationship.
Latest:
Dr. Lara reviews the evolving systemic therapy paradigm in renal cell carcinoma“The question of who is a candidate for active surveillance is hard to answer because this is a bedside, gut decision," says Primo Nery Lara, Jr, MD.
Latest:
The management of high-risk localized prostate cancer: Back to the future"I predict the future treatment for men with truly high-risk prostate cancer will see a fusion of what was thought to be standard local treatments combined with multimodality therapies that were initially impactful only in the more advanced disease state," writes Michael S. Cookson, MD, MMHC, FACS.
Latest:
Tips for optimizing productivity and collaboration for trainees who go unmatched in urology"Going into the upcoming application cycle, I am now a bit more excited and a little less terrified," writes Leah Ashton, MD.
Latest:
Leveraging technology to empower patients and reduce physician burnoutImplementing the right practice technology can not only mitigate physician burnout, it can also enable patients to take charge of their own care experience.
Latest:
Expert shares best practices for keeping a medical office cleanHere are 5 best practices for cleaning a medical office.
Latest:
PARP inhibitors: Treating mCRPC from a genetic basisTreatments provide a targeted therapeutic strategy for metastatic castration-resistant prostate cancer.
Latest:
Artificial intelligence is the new ghost author in urological research“Although the future of AI within science is uncertain, disclosure of the use of AI is an excellent first step to balance academic integrity with disruptive innovation,” the authors write.
Latest:
Future Landscape of Prostate Cancer and Rectal SpacersThe expert panel concludes their discussion with a look toward the future of prostate cancer treatment and the evolving role of rectal spacers.
Latest:
Workplace violence in health care remains rampant as preventive efforts continueEven before the pandemic, violence against health care workers was escalating.
Latest:
FDA approves niraparib/abiraterone tablet for BRCA-positive mCRPCThe approval of the niraparib/abiraterone dual-action tablet for BRCA-positive mCRPC is based on findings from the phase 3 MAGNITUDE study.
Latest:
Closing Thoughts on Urology Practice Management and Treatment of Advanced Prostate CancerClosing out their discussion on how treatment and management of advanced prostate cancer affects their clinical practice, expert urologists consider how the therapeutic landscape continues to evolve and look toward future evolutions in care.
Latest:
Multicomponent intervention linked with improved QOL in patients with OABIn the intervention group, the HRQOL score changed by 23.9 points between baseline and week 13, from 18.4 to 29.5.
Latest:
Fluoroscopic Imaging and Other Developments in UrologyThe rationale for utilizing fluoroscopic imaging as well as other evolving technologies that are currently being developed and explored in urology.
